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Fig.　1　Individual data for 11 consenting patients show that the PvO2 levels were marked-
ly elevated at the time of an emergency hospital visit and admission and gradually declined 
during therapy. All blood samples were obtained by venipuncture of the median cubital vein 
or forearm vein when blood cell and/or chemistry analysis was necessary. An aliquot of 
each sample was introduced directly into a gas analysis syringe and subjected to gas mea-
surement within two minutes. The venous blood thus made no signifi cant contact with room 
air, and contamination by arterial blood was unlikely. A pulse oxymeter indicated that O2 
saturation of the arterial blood was well maintained during venous blood sampling from the 
patients.
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Dear Editor
Some asthmatics show elevation of
the peripheral venous oxygen
pressure (PvO2)
Bronchial asthma is a common disease, characterized
by reversible narrowing and hyperresponsiveness of
the airways. Evaluation of airflow limitation and air-
way hypersensitivity is useful for objective assess-
ment of asthma.1,2 However, these tests may not be
sufficient to fully elucidate the exact condition of
asthma. During the course of many years of clinical
experience, we noticed that some asthmatics present
a contradiction by having a decent peak flow even
while experiencing persistent dyspnea. We thus hy-
pothesized that some other internal factor might be
involved in the causation of some cases of dyspnea.
While searching for novel objective indices, ap-
proximately eight years ago we found marked eleva-
tion of the peripheral venous oxygen pressure (PvO2)
in an asthmatic subject. Further careful analysis led
to a belief that said finding was reproducible and not
erroneous, and was in fact occasionally seen in a
small number of exacerbated asthmatics. 3-6 There
were no signs of circulatory disturbances such as ve-
nous dilatation or peripheral temperature decline.
Those deteriorating patients appeared to share sev-
eral clinical features of not feeling well : lassitude,
shortness of breath, palpitation and easy fatigability,
combined with mild to moderate airflow limitation,
and they each fulfilled the diagnostic criteria for
asthma.2 Besides having very high PvO2 levels, they
were intractable asthmatics who had responded
poorly to a series of rescue medications and required
hospitalization. Figure 1 plots the individual time-
course data for PvO2 obtained from 11 such patients
without oxygen inhalation. Surprisingly, they initially
showed an extraordinarily high PvO2 (78.5 ± 16.9
Torr, n = 11) (median ± SD) (shown as the origin of
Fig. 1) , similar to that usually observed in arterial
blood. The levels of PvCO2 (38.8 ± 4.9 Torr, n = 11)
also corresponded to the normal partial pressure of
carbon dioxide in the arterial blood (PaCO2). In clear
contrast, the gas data for other severe, moderate or
mild asthmatics, either stable or unstable, were
within a narrow range and essentially the same as for
healthy subjects (asthmatics without PvO2 elevation:
PvO2 22.4 ± 7.3 Torr, PvCO2 48.6 ± 4.7 Torr, n = 36;
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healthy: PvO2 26.4 ± 10.2 Torr, PvCO2 47.8 ± 5.4
Torr, n = 26). As demonstrated in the figure, these
very high PvO2 levels gradually decreased, and in-
versely, PvCO2 gradually increased (data not shown)
during hospitalization, accompanied by alleviation of
the dyspnea. Even high-dose systemic steroid ther-
apy of these 11 patients failed to induce a rapid de-
crease in the PvO2 level or rapid symptomatic relief.
Oxygen inhalation often mildly alleviated their dysp-
nea. The most effective overall treatment for their
symptoms, including fatigue, was rest.
We now believe that these gas analysis data clearly
indicate the existence of a systemic mechanism driv-
ing PvO2 elevation in some deteriorating asthmatics.
Why and how their PvO2 elevation occurs and is
maintained, whether their airway inflammation is
unique and the prevalence of such patients among
asthmatics remain to be elucidated. Another impor-
tant point is identification of a specific clinical
biomarker in these patients that would be indicative
of an elevated PvO2 level during asthma exacerba-
tion. At present, potentially useful clues for identify-
ing these patients may be exertional breathlessness
that seems out of proportion to the objective asth-
matic state and a strangely bright red color of venous
blood samples. Our preliminary analysis showed that
the serum levels of lactate and pyruvate were ele-
vated in these deteriorating patients, suggesting in-
sufficient tissue oxygenation. 5 We presume that a
high PvO2 level translates into an inadequate oxygen
supply and decreased consumption in peripheral tis-
sues, leading to the lassitude, shortness of breath and
easy fatigability seen in these deteriorating asthmat-
ics.
The results shown herein were presented in part at
academic meetings and have been published in ab-
stract form.3-6
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